Recent Patents, Regulatory Issues, and Toxicity of Nanoparticles in Neuronal Disorders.

Muheem, Abdul; Jahangir, Mohammed A; Jaiswal, Chandra P; Jafar, Mohammed; Ahmad, Mohammad Z; Ahmad, Javed; Warsi, Musarrat H

Muheem, Abdul; Jahangir, Mohammed A; Jaiswal, Chandra P; Jafar, Mohammed; Ahmad, Mohammad Z; Ahmad, Javed; Warsi, Musarrat H.

Affiliation

Muheem A; Department of Pharmaceutics, School of Pharmaceutical Education & Research, Jamia Hamdard, New Delhi-110062, India.
Jahangir MA; Department of Pharmaceutics, Nibha Institute of Pharmaceutical Sciences, Rajgir, Nalanda-803116, Bihar, India.
Jaiswal CP; Research & Development Center, Sentiss Pharma Pvt. Ltd., Gurugram, Haryana-122001, India.
Jafar M; Department of Pharmaceutics, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia.
Ahmad MZ; Department of Pharmaceutics, College of Pharmacy, Najran University, Najran, Saudi Arabia.
Ahmad J; Department of Pharmaceutics, College of Pharmacy, Najran University, Najran, Saudi Arabia.
Warsi MH; Department of Pharmaceutics and Industrial Pharmacy, College of Pharmacy, Taif University, Taif-Al-Haweiah 21974, Saudi Arabia.

Curr Drug Metab ; 22(4): 263-279, 2021.

Article in En | MEDLINE | ID: mdl-33305703

Subject(s)
Key words

Toxicity; brain diseases; nanoparticles; neuronal disorder; patent.; regulatory

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Patents as Topic / Neuroprotective Agents / Theranostic Nanomedicine / Nanoparticle Drug Delivery System / Nervous System Diseases Type of study: Diagnostic_studies / Guideline / Prognostic_studies / Risk_factors_studies Limits: Animals / Humans Language: En Journal: Curr Drug Metab Journal subject: METABOLISMO / QUIMICA Year: 2021 Document type: Article Affiliation country: India Country of publication: Países Bajos

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google